340 related articles for article (PubMed ID: 28700444)
1. Multi-institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-risk Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Al Efishat MA; Attiyeh MA; Eaton AA; Gönen M; Prosser D; Lokshin AE; Castillo CF; Lillemoe KD; Ferrone CR; Pergolini I; Mino-Kenudson M; Rezaee N; Dal Molin M; Weiss MJ; Cameron JL; Hruban RH; D'Angelica MI; Kingham TP; DeMatteo RP; Jarnagin WR; Wolfgang CL; Allen PJ
Ann Surg; 2018 Aug; 268(2):340-347. PubMed ID: 28700444
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium.
Attiyeh MA; Fernández-Del Castillo C; Al Efishat M; Eaton AA; Gönen M; Batts R; Pergolini I; Rezaee N; Lillemoe KD; Ferrone CR; Mino-Kenudson M; Weiss MJ; Cameron JL; Hruban RH; D'Angelica MI; DeMatteo RP; Kingham TP; Jarnagin WR; Wolfgang CL; Allen PJ
Ann Surg; 2018 Jan; 267(1):157-163. PubMed ID: 28079542
[TBL] [Abstract][Full Text] [Related]
3. Multiinstitutional Validation Study of Cyst Fluid Protein Biomarkers in Patients With Cystic Lesions of the Pancreas.
McIntyre CA; Rodrigues C; Santharaman AV; Goldman DA; Javed AA; Ciprani D; Pang N; Lokshin A; Gonen M; Al Efishat MA; He J; Burkhart R; Burns W; Weiss M; D'Angelica MI; Kingham TP; Balachandran VP; Drebin JA; Jarnagin WR; Lillemoe KD; Brugge W; Casey B; Lennon AM; Schattner M; Wolfgang CL; Del Castillo CF; Allen PJ
Ann Surg; 2022 Aug; 276(2):e129-e132. PubMed ID: 34793354
[TBL] [Abstract][Full Text] [Related]
4. External validation of nomogram for predicting malignant intraductal papillary mucinous neoplasm (IPMN): from the theory to the clinical practice using the decision curve analysis model.
Casadei R; Ricci C; Ingaldi C; Cornacchia A; Migliori M; Di Marco M; Pagano N; Serra C; Alberici L; Minni F
Updates Surg; 2021 Apr; 73(2):429-438. PubMed ID: 33620642
[TBL] [Abstract][Full Text] [Related]
5. Validation of a nomogram for predicting the probability of carcinoma in patients with intraductal papillary mucinous neoplasm in 180 pancreatic resection patients at 3 high-volume centers.
Shimizu Y; Yamaue H; Maguchi H; Yamao K; Hirono S; Osanai M; Hijioka S; Kanemitsu Y; Sano T; Senda Y; Bhatia V; Yanagisawa A
Pancreas; 2015 Apr; 44(3):459-64. PubMed ID: 25423557
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E
Yip-Schneider MT; Carr RA; Wu H; Schmidt CM
J Am Coll Surg; 2017 Oct; 225(4):481-487. PubMed ID: 28739154
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic Fluid Interleukin-1β Complements Prostaglandin E2 and Serum Carbohydrate Antigen 19-9 in Prediction of Intraductal Papillary Mucinous Neoplasm Dysplasia.
Simpson RE; Yip-Schneider MT; Flick KF; Wu H; Colgate CL; Schmidt CM
Pancreas; 2019 Sep; 48(8):1026-1031. PubMed ID: 31404023
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and Prognostic Impact of Neutrophil-to-Lymphocyte Ratio for Intraductal Papillary Mucinous Neoplasms of the Pancreas With High-Grade Dysplasia and Associated Invasive Carcinoma.
Hata T; Mizuma M; Motoi F; Ishida M; Morikawa T; Takadate T; Nakagawa K; Hayashi H; Kanno A; Masamune A; Kamei T; Furukawa T; Naitoh T; Unno M
Pancreas; 2019 Jan; 48(1):99-106. PubMed ID: 30540681
[TBL] [Abstract][Full Text] [Related]
9. Develop Nomogram to Predict Malignancy of Intraductal Papillary Mucinous Neoplasm.
Kim Y; Park T
Methods Mol Biol; 2019; 1882():23-32. PubMed ID: 30378041
[TBL] [Abstract][Full Text] [Related]
10. Novel Methylated DNA Markers Discriminate Advanced Neoplasia in Pancreatic Cysts: Marker Discovery, Tissue Validation, and Cyst Fluid Testing.
Majumder S; Taylor WR; Yab TC; Berger CK; Dukek BA; Cao X; Foote PH; Wu CW; Mahoney DW; Aslanian HR; Fernández-Del Castillo C; Doyle LA; Farrell JJ; Fisher WE; Lee LS; Lee YN; Park W; Rodrigues C; Gould Rothberg BE; Salem RR; Simeone DM; Urs S; Van Buren G; Smyrk TC; Allawi HT; Lidgard GP; Raimondo M; Chari ST; Kendrick ML; Kisiel JB; Topazian MD; Ahlquist DA
Am J Gastroenterol; 2019 Sep; 114(9):1539-1549. PubMed ID: 31306149
[TBL] [Abstract][Full Text] [Related]
11. Development, validation, and comparison of a nomogram based on radiologic findings for predicting malignancy in intraductal papillary mucinous neoplasms of the pancreas: An international multicenter study.
Kim HS; Song W; Choo W; Lee S; Han Y; Bassi C; Salvia R; Marchegiani G; Wolfgang CL; He J; Blair AB; Kluger MD; Su GH; Kim SC; Song KB; Yamamoto M; Hatori T; Yang CY; Yamaue H; Hirono S; Satoi S; Fujii T; Hirano S; Lou W; Hashimoto Y; Shimizu Y; Del Chiaro M; Valente R; Lohr M; Choi DW; Choi SH; Heo JS; Motoi F; Matsumoto I; Lee WJ; Kang CM; Shyr YM; Wang SE; Han HS; Yoon YS; Besselink MG; van Huijgevoort NCM; Sho M; Nagano H; Kim SG; Honda G; Yang Y; Yu HC; Yang JD; Chung JC; Nagakawa Y; Seo HI; Lee S; Kim H; Kwon W; Park T; Jang JY
J Hepatobiliary Pancreat Sci; 2023 Jan; 30(1):133-143. PubMed ID: 33811460
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic cyst fluid concentration of high-mobility group A2 protein acts as a differential biomarker of dysplasia in intraductal papillary mucinous neoplasm.
DiMaio CJ; Weis-Garcia F; Bagiella E; Tang LH; Allen PJ
Gastrointest Endosc; 2016 Jun; 83(6):1205-9. PubMed ID: 26408423
[TBL] [Abstract][Full Text] [Related]
13. Radiomic nomogram based on MRI to predict grade of branching type intraductal papillary mucinous neoplasms of the pancreas: a multicenter study.
Cui S; Tang T; Su Q; Wang Y; Shu Z; Yang W; Gong X
Cancer Imaging; 2021 Mar; 21(1):26. PubMed ID: 33750453
[TBL] [Abstract][Full Text] [Related]
14. Computed tomography nomogram to predict a high-risk intraductal papillary mucinous neoplasm of the pancreas.
Fang X; Liu F; Li J; Cao K; Wang T; Zhang H; Li Q; Meng Y; Yu J; Feng X; Jiang H; Wang L; Lu J; Shao C; Bian Y
Abdom Radiol (NY); 2021 Nov; 46(11):5218-5228. PubMed ID: 34409514
[TBL] [Abstract][Full Text] [Related]
15. Next generation sequencing of the cellular and liquid fraction of pancreatic cyst fluid supports discrimination of IPMN from pseudocysts and reveals cases with multiple mutated driver clones: First findings from the prospective ZYSTEUS biomarker study.
Volckmar AL; Endris V; Gaida MM; Leichsenring J; Stögbauer F; Allgäuer M; von Winterfeld M; Penzel R; Kirchner M; Brandt R; Neumann O; Sültmann H; Schirmacher P; Rudi J; Schmitz D; Stenzinger A
Genes Chromosomes Cancer; 2019 Jan; 58(1):3-11. PubMed ID: 30230086
[TBL] [Abstract][Full Text] [Related]
16. Cyst fluid interleukin-1beta (IL1beta) levels predict the risk of carcinoma in intraductal papillary mucinous neoplasms of the pancreas.
Maker AV; Katabi N; Qin LX; Klimstra DS; Schattner M; Brennan MF; Jarnagin WR; Allen PJ
Clin Cancer Res; 2011 Mar; 17(6):1502-8. PubMed ID: 21266527
[TBL] [Abstract][Full Text] [Related]
17. Proposed Nomogram Predicting the Individual Risk of Malignancy in the Patients With Branch Duct Type Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Jang JY; Park T; Lee S; Kim Y; Lee SY; Kim SW; Kim SC; Song KB; Yamamoto M; Hatori T; Hirono S; Satoi S; Fujii T; Hirano S; Hashimoto Y; Shimizu Y; Choi DW; Choi SH; Heo JS; Motoi F; Matsumoto I; Lee WJ; Kang CM; Han HS; Yoon YS; Sho M; Nagano H; Honda G; Kim SG; Yu HC; Chung JC; Nagakawa Y; Seo HI; Yamaue H
Ann Surg; 2017 Dec; 266(6):1062-1068. PubMed ID: 27607098
[TBL] [Abstract][Full Text] [Related]
18. Cyst Fluid Biosignature to Predict Intraductal Papillary Mucinous Neoplasms of the Pancreas with High Malignant Potential.
Maker AV; Hu V; Kadkol SS; Hong L; Brugge W; Winter J; Yeo CJ; Hackert T; Büchler M; Lawlor RT; Salvia R; Scarpa A; Bassi C; Green S
J Am Coll Surg; 2019 May; 228(5):721-729. PubMed ID: 30794864
[TBL] [Abstract][Full Text] [Related]
19. Cyst fluid carcinoembryonic antigen level is not predictive of invasive cancer in patients with intraductal papillary mucinous neoplasm of the pancreas.
Kucera S; Centeno BA; Springett G; Malafa MP; Chen YA; Weber J; Klapman J
JOP; 2012 Jul; 13(4):409-13. PubMed ID: 22797397
[TBL] [Abstract][Full Text] [Related]
20. Humoral Predictors of Malignancy in IPMN: A Review of the Literature.
Nista EC; Schepis T; Candelli M; Giuli L; Pignataro G; Franceschi F; Gasbarrini A; Ojetti V
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]